$3.460
-0.144 (-4.16%)At close
- High
- 3.960
- Open
- 3.960
- VWAP
- 3.55
- Vol
- 521.11K
- Mkt Cap
- 50.76M
- Low
- 3.220
- Amount
- 1.85M
- EV/EBITDA, TTM
- 0.00
Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body.
AI analysis of Modular Medical Inc (MODD)
buyModular Medical Inc is a good buy right now due to its recent FDA clearance for a next-generation insulin patch pump, which has the potential to significantly increase market share. The current price is $3.46, and the stock has shown a 20-day change of +44.77%, indicating strong momentum. However, the company has reported consistent losses, with a net income of -7,790,000 USD in Q2 2026, which remains a risk for investors.
Valuation Metrics
Events Timeline
News
8.507-01NewsfilterModular Medical Submits Software Enhancements for Pivot Insulin Delivery System
2.005-21NASDAQ.COMHCW Biologics Stock Surges 129% Amid Concerns
8.504-29NewsfilterModular Medical Unveils New Insulin Pump Technology
8.504-20seekingalphaModular Medical Prices Direct Offering of 750K Shares
8.504-20Yahoo FinanceModular Medical Prices Direct Offering of 750,000 Shares
MODD FAQ — answered by Alphio AI
Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Modular Medical Inc is a good buy right now due to its recent FDA clearance for a next-generation insulin patch pump, which has the potential to significantly increase market share. The current price is $3.46, and the stock has shown a 20-day change of +44.77%, indicating strong momentum. However, the company has reported consistent losses, with a net income of -7,790,000 USD in Q2 2026, which remains a risk for investors.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.